A Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis Interventions: Drug: TAK-079; Drug: TAK-079 Placebo Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials